Furthermore, the NLRP3 inflammasome inhibitor MCC950 ameliorates cognitive disorders as well as anxiety- and depression-like behaviors in db/db mice, which is associated with the inhibition of hippocampal NLRP3 inflammasome activation. Here, NLRP3 is linked to depressive symptom measurement.